Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cibinetide for Sale > BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - large image1
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - image1
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - image2
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - image3
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - image4
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - image5
BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder buy - image6

BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder

KOSHER ISO TDS 20 Inquiries

Unit Price: Get Latest Price
CAS No.:

1208243-50-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chinese mainland

Brand:

any

Packaging:

5mg 10 mg*10vials

Price valid (until):

2026-07-03

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)

  • Product Description

  • Seller Information

  • History Price

  • Inquiry History

  • Description


      Product Detail  


    Pls input...

    WhatsApp:+852 69950211



    1. Indications:

      BPC is an artificially synthesized highly active peptide/bioactive molecule, prepared using advanced solid-phase synthesis technology, with a purity of ≥99%, stable batch size, high activity, and controllable impurities. As a research-grade specialized reagent, it is suitable for cell experiments, mechanism studies, pharmacological exploration, formulation development, and other research scenarios, providing high-quality experimental materials for related research.

       Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.


      1.     1.Treatment of depression and anxiety disorders:  Retatrutide  has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
      2.     2.Prevention of neurodegenerative diseases:  Retatrutide  has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
      3.     3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
      4.     4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
      5.     5.Promotion of wound healing:  Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.

    Certificates
    • BPC |e 99% Purity 5mg 10mg Vials Bpc Lyophilized Powder Certificates 3

    Basic Info
    Product Name:

    Cibinetide

    Other Name:

    ARA-290 (Cibinetide);ARA290, >98%;ARA290,Cibinetide, >98%;ARA290;WZTIQQBMSJTRBR-MUZUOSMHSA-N;ara290/Poziotinib;L-Serine, 5-oxo-L-prolyl-L-α-glutamyl-L-glutaminyl-L-leucyl-L-α-glutamyl-L-arginyl-L-alanyl-L-leucyl-L-asparaginyl-L-seryl-;ARA-290(Cibinetide) acetate

    CAS No.:

    1208243-50-8

    Molecular Formula:

    C51H84N16O21

    InChIKeys:

    WZTIQQBMSJTRBR-WYKNNRPVSA-N

    Molecular Weight:

    1257.31

    EC Number:

    200-001-8

    Color/Form:

    White to off-white

    Characteristics
    Density:

    1.56±0.1 g/cm3(Predicted)

    PKA:

    2.90±0.10(Predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)

    Location:

    Room 1002-C3973, No. 80, Yongtai Modaonan Street, Yongping Subdistrict, Baiyun District, Guangzhou City

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    45

    Year of Establishment:

    2026

    Anymang is a US-based trading company dedicated to the global supply and formulation of high-quality cosmetic raw materials, with a core focus on peptide ingredients. Committed to bridging premium suppliers and beauty manufacturers worldwide, we deliver pure, stable, and efficacious peptides—including anti-aging, brightening, and firming peptides—alongside a full spectrum of cosmetic actives and custom formulation solutions. With rigorous quality control and compliance with US safety standards, we ensure consistent batch quality and reliable delivery. Our experienced team provides professional technical support and tailored services to help clients develop competitive skincare and personal care products. Trusted by partners across the globe, Anymang stands as your dependable partner for innovative, high-performance cosmetic raw materials and peptide formulations.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    20 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Factory Supply 99% Purity Ara 290 Peptides Raw Lyophilized Powder CAS 1208243-50-8

    1 G Oct 29, 2023
    United States

    ARA 290

    1 G Apr 13, 2026
    United States

    ARA-290 Peptide

    1 G Feb 6, 2026
    United States

    ARA-290

    10 PCS Nov 15, 2025
    Thailand

    Cibinetide

    200 KG May 10, 2025
    Lithuania

    ARA 290

    60  Nov 28, 2023
    United States

    ARA 290

    1 KG Jun 15, 2026
    Belgium

    ARA290

    1 KG May 20, 2026
    United States

    Reta

    60  May 4, 2026
    United States

    ARA-290 Lyophilized

    800 MG Apr 17, 2026
    United States

    Ara290

    1 G Apr 17, 2026
    Nigeria

    Snap 8

    100 PCS Apr 10, 2026
    United States

    Ara 290

    1 G Apr 8, 2026
    United States

    ARA-290

    1 G Apr 5, 2026
    Bulgaria

    ARA-290 98%

    5 KG Jun 5, 2025
    Denmark

    Cibinetide

    5 G Feb 10, 2024
    United States

    ARA-290 10mg

    100 PCS Apr 17, 2026
    United States

    ARA-290

    10 MT May 10, 2024
    Denmark

    Cibinetide

    5 G Feb 11, 2024
    Lithuania

    ARA 290

    10  Nov 28, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.